Top

Published in:

01-08-2020 | Obesity | Original Contributions

Intragastric Balloon Versus Endoscopic Sleeve Gastroplasty for the Treatment of Obesity: a Systematic Review and Meta-analysis

Authors: Shailendra Singh, Diogo Turiani Hourneaux de Moura, Ahmad Khan, Mohammad Bilal, Monica Chowdhry, Michele B. Ryan, Ahmad Najdat Bazarbashi, Christopher C. Thompson

Published in: Obesity Surgery | Issue 8/2020

Abstract

Background

We aimed to individually evaluate IGB and ESG procedures and compare the efficacy, durability, and safety of these procedures.

Methods

Bibliographic databases were systematically searched for studies investigating the use of IGB and ESG for the treatment of obesity. Studies reporting percent total weight loss (%TWL) or percent excess weight loss (%EWL) with at least 12 months of follow-up were included.

Results

A total of 28 studies were included in the final analysis. Only 1 study directly compared ESG to IGB, 9 studies evaluated ESG alone, while 18 studies evaluated IGB. At 12-month follow-up after ESG, mean %TWL was 17.51 (95% CI 16.44–18.58), and %EWL was 60.51 (95% CI 54.39–66.64). Mean %TWL and %EWL after IGB at 12 months was 10.35 (95% CI 8.38–12.32) and 29.65 (95% CI 25.40–33.91), respectively. Mean %TWL and %EWL after IGB were significantly decreased at 18 or 24 months compared to 6 months indicating weight regain after IGB removal. ESG achieved significantly superior weight loss compared to IGB, the difference in mean %TWL was 7.33 (95% CI 5.22–9.44, p value = 0.0001) at 12 months. Serious adverse events were observed in < 5% for both procedures.

Conclusion

Although ESG and IGB are safe and effective for weight loss, our study suggests that ESG results in more significant and sustained weight loss. Nevertheless, a variety of approaches are essential to care for this underserved population, and there are several factors other than weight loss that should be considered in selecting the ideal therapy for individual patients.

Available only for authorised users

Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg 2013 23(4):427-436.

Abu Dayyeh BK, Kumar N, Edmundowicz SA, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82:425–438.e5. https://doi.org/10.1016/j.gie.2015.03.1964.CrossRefPubMed

Moura D, Oliveira J, De Moura EGH, et al. Effectiveness of intragastric balloon for obesity: a systematic review and meta-analysis based on randomized control trials. Surg Obes Relat Dis. 2016;12:420–9. https://doi.org/10.1016/j.soard.2015.10.077.CrossRefPubMed

Kotinda APST, de Moura DTH, Ribeiro IB, et al. Efficacy of intragastric balloons for weight loss in overweight and obese adults: a systematic review and meta-analysis of randomized controlled trials. Obes Surg. 2020; https://doi.org/10.1007/s11695-020-04558-5.

Kumar N, Lopez-Nava G, Sahdala HNP, et al. Endoscopic sleeve gastroplasty: multicenter weight loss results. Gastroenterology. 2015;

Singh S, Hourneaux de Moura DT, Khan A, et al. Safety and efficacy of endoscopic sleeve gastroplasty worldwide for treatment of obesity: a systematic review and meta-analysis. Surg Obes Relat Dis. 2020; https://doi.org/10.1016/j.soard.2019.11.012.

de Miranda Neto AA, de Moura DTH, Ribeiro IB, et al. Efficacy and safety of endoscopic sleeve gastroplasty at mid term in the management of overweight and obese patients: a systematic review and meta-analysis. Obes Surg. 2020;30:1971–87. https://doi.org/10.1007/s11695-020-04449-9.CrossRefPubMed

Ginsberg GG, Chand B, Cote GA, et al. A pathway to endoscopic bariatric therapies. Gastrointest Endosc. 2011;74:943–53. https://doi.org/10.1016/j.gie.2011.08.053.CrossRefPubMed

Saumoy M, Schneider Y, Zhou XK, et al. A single-operator learning curve analysis for the endoscopic sleeve gastroplasty. Gastrointest Endosc. 2018;87:442–7. https://doi.org/10.1016/j.gie.2017.08.014.CrossRefPubMed

10.

Sartoretto A, Marinos G, Sui Z. Endoscopic sleeve gastroplasty for obesity: improved body composition at 1-year follow-up. Gastrointest Endosc. 2019;89:AB260. https://doi.org/10.1016/j.gie.2019.03.292.CrossRef

11.

Graus Morales J, Crespo Pérez L, Marques A, et al. Modified endoscopic gastroplasty for the treatment of obesity. Surg Endosc. 2018;32:3936–42. https://doi.org/10.1007/s00464-018-6133-0.CrossRefPubMed

12.

Lopez-Nava G, Galvão MP, Bautista-Castaño I, et al. Endoscopic sleeve gastroplasty for obesity treatment: two years of experience. Arq Bras Cir Dig. 2017;30:18–20. https://doi.org/10.1590/0102-6720201700010006.CrossRefPubMedPubMedCentral

13.

Kumar N, Abu Dayyeh BK, Lopez-Nava Breviere G, et al. Endoscopic sutured gastroplasty: procedure evolution from first-in-man cases through current technique. Surg Endosc. 2018;32:2159–64. https://doi.org/10.1007/s00464-017-5869-2.CrossRefPubMed

14.

Bhandari M, Jain S, Mathur W, et al. Endoscopic sleeve gastroplasty is an effective and safe minimally invasive approach for treatment of obesity: first Indian experience. Dig Endosc. 2019:den.13508. https://doi.org/10.1111/den.13508.

15.

Barrichello S, Hourneaux de Moura DT, Hourneaux de Moura EG, et al. Endoscopic sleeve gastroplasty in the management of overweight and obesity: an international multicenter study. Gastrointest Endosc. 2019; https://doi.org/10.1016/j.gie.2019.06.013.

16.

Alqahtani A, Al-Darwish A, Mahmoud AE, et al. Short-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients. Gastrointest Endosc. 2019;89(6):1132–8. https://doi.org/10.1016/j.gie.2018.12.012.CrossRefPubMed

17.

Abu Dayyeh BK, Acosta A, Camilleri M, et al. Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin Gastroenterol Hepatol. 2017;15(1):37–43.e1. https://doi.org/10.1016/j.cgh.2015.12.030.CrossRefPubMed

18.

Fayad L, Cheskin LJ, Adam A, et al. Endoscopic sleeve gastroplasty versus intragastric balloon insertion: efficacy, durability, and safety. Endoscopy. 2019;51:532–9. https://doi.org/10.1055/a-0852-3441.CrossRefPubMed

19.

Agnihotri A, Xie A, Bartalos C, et al. Real-world safety and efficacy of fluid-filled dual intragastric balloon for weight loss. Clin Gastroenterol Hepatol. 2018;16:1081–1088.e1. https://doi.org/10.1016/j.cgh.2018.02.026.CrossRefPubMed

20.

Angrisani L, Lorenzo M, Borrelli V, et al. Is bariatric surgery necessary after intragastric balloon treatment? Obes Surg. 2006;16:1135–7. https://doi.org/10.1381/096089206778392365.CrossRefPubMed

21.

Ashrafian H, Monnich M, Braby TS, et al. Intragastric balloon outcomes in super-obesity: a 16-year city center hospital series. Surg Obes Relat Dis. 2018;14:1691–9. https://doi.org/10.1016/j.soard.2018.07.010.CrossRefPubMed

22.

Bozkurt S, Coskun H. The early results of intragastric balloon application of different BMI groups. Eur Surg - Acta Chir Austriaca. 2012;44:383–7. https://doi.org/10.1007/s10353-012-0167-7.CrossRef

23.

Courcoulas A, Abu Dayyeh BK, Eaton L, et al. Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial. Int J Obes. 2017;41:427–33. https://doi.org/10.1038/ijo.2016.229.CrossRef

24.

Crea N, Pata G, Della Casa D, et al. Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg. 2009;19:1084–8. https://doi.org/10.1007/s11695-009-9879-6.CrossRefPubMed

25.

Dargent J, Mion F, Costil V, et al. Multicenter randomized study of obesity treatment with minimally invasive injection of hyaluronic acid versus and combined with intragastric balloon. Obes Surg. 2015;25:1842–7. https://doi.org/10.1007/s11695-015-1648-0.CrossRefPubMed

26.

Dogan UB, Gumurdulu Y, Akin MS, et al. Five percent weight lost in the first month of intragastric balloon treatment may be a predictor for long-term weight maintenance. Obes Surg. 2013;23:892–6. https://doi.org/10.1007/s11695-013-0876-4.CrossRefPubMed

27.

Farina MG, Baratta R, Nigro A, et al. Intragastric balloon in association with lifestyle and/or pharmacotherapy in the long-term management of obesity. Obes Surg. 2012;22:565–71. https://doi.org/10.1007/s11695-011-0514-y.CrossRefPubMed

28.

Fuller NR, Pearson S, Lau NS, et al. An intragastric balloon in the treatment of obese individuals with metabolic syndrome: a randomized controlled study. Obesity. 2013;21:1561–70. https://doi.org/10.1002/oby.20414.CrossRefPubMed

29.

Genco A, Balducci S, Bacci V, et al. Intragastric balloon or diet alone? A retrospective evaluation. Obes Surg. 2008;18:989–92. https://doi.org/10.1007/s11695-007-9383-9.CrossRefPubMed

30.

Genco A, Cipriano M, Materia A, et al. Laparoscopic sleeve gastrectomy versus intragastric balloon: a case-control study. Surg Endosc. 2009;23:1849–53. https://doi.org/10.1007/s00464-008-0285-2.CrossRefPubMed

31.

Herve J, Wahlen CH, Schaeken A, et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg. 2005;15:864–70. https://doi.org/10.1381/0960892054222894.CrossRefPubMed

32.

Al Kahtani K, Khan MQ, Helmy A, et al. Bio-enteric intragastric balloon in obese patients: a retrospective analysis of King Faisal specialist hospital experience. Obes Surg. 2010;20:1219–26. https://doi.org/10.1007/s11695-008-9654-0.CrossRefPubMed

33.

Kotzampassi K, Grosomanidis V, Papakostas P, et al. 500 intragastric balloons: what happens 5 years thereafter? Obes Surg. 2012;22:896–903. https://doi.org/10.1007/s11695-012-0607-2.CrossRefPubMed

34.

Mui WLM, Ng EKW, Tsung BYS, et al. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2010;20:1128–32. https://doi.org/10.1007/s11695-008-9766-6.CrossRefPubMed

35.

Nikolic M, Boban M, Ljubicic N, et al. Morbidly obese are ghrelin and leptin hyporesponders with lesser intragastric balloon treatment efficiency: ghrelin and leptin changes in relation to obesity treatment. Obes Surg. 2011;21:1597–604. https://doi.org/10.1007/s11695-011-0414-1.CrossRefPubMed

36.

Sallet JA, Marchesini JB, Paiva DS, et al. Brazilian multicenter study of the intragastric balloon. Obes Surg. 2004;14:991–8. https://doi.org/10.1381/0960892041719671.CrossRefPubMed

37.

Sartoretto A, Sui Z, Hill C, et al. Endoscopic sleeve gastroplasty (ESG) is a reproducible and effective endoscopic bariatric therapy suitable for widespread clinical adoption: a large, international multicenter study. Obes Surg. 2018;28:1812–21. https://doi.org/10.1007/s11695-018-3135-x.CrossRefPubMed

38.

Neto MG, Moon RC, de Quadros LG, et al. Safety and short-term effectiveness of endoscopic sleeve gastroplasty using overstitch: preliminary report from a multicenter study. Surg Endosc. 2019; https://doi.org/10.1007/s00464-019-07212-z.

39.

Tate CM, Geliebter A. Intragastric balloon treatment for obesity: review of recent studies. Adv Ther. 2017;34:1859–75. https://doi.org/10.1007/s12325-017-0562-3.CrossRefPubMed

40.

Genco A, López-Nava G, Wahlen C, et al. Multi-centre European experience with intragastric balloon in overweight populations: 13 years of experience. Obes Surg. 2013;23:515–21. https://doi.org/10.1007/s11695-012-0829-3.CrossRefPubMed

41.

Abu Dayyeh BK, Noar MD, Lavin T, et al. 176 pivotal randomized-controlled trial of the adjustable (SPATZ-3) intragastric balloon system for weight loss. Gastrointest Endosc. 2019;89:AB58–9. https://doi.org/10.1016/j.gie.2019.04.020.CrossRef

42.

Kumar N, Sullivan S, Thompson CC. The role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy. Diabetes, Metab Syndr Obes Targets Ther. 2017; https://doi.org/10.2147/DMSO.S95118.

43.

Shah SL, Hajifathalian K, Mehta A, et al. 1105 – impact of concurrent pharmacotherapy with intragastric balloons in the treatment of obesity. Gastroenterology. 2019;156:S–236. https://doi.org/10.1016/s0016-5085(19)37390-1.CrossRef

44.

Ball W, Raza SS, Loy J, et al. Effectiveness of intra-gastric balloon as a bridge to definitive surgery in the super obese. Obes Surg. 2019;29:1932–6. https://doi.org/10.1007/s11695-019-03794-8.CrossRefPubMed

45.

Alqahtani AR, Elahmedi M, Alqahtani YA, et al. Laparoscopic sleeve gastrectomy after endoscopic sleeve gastroplasty: technical aspects and short-term outcomes. Obes Surg. 2019;29:3547–52. https://doi.org/10.1007/s11695-019-04024-x.CrossRefPubMed

46.

Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010;71:446–54. https://doi.org/10.1016/j.gie.2009.10.027.CrossRefPubMed

47.

Bazerbachi F, Haffar S, Sawas T, et al. Fluid-filled versus gas-filled intragastric balloons as obesity interventions: a network meta-analysis of randomized trials. Obes Surg. 2018;28:2617–25. https://doi.org/10.1007/s11695-018-3227-7.CrossRefPubMed

48.

Bazerbachi F, Vargas EJ, Abu Dayyeh BK. Endoscopic bariatric therapy. Am J Gastroenterol. 2019; https://doi.org/10.14309/ajg.0000000000000239.

49.

Title: Intragastric Balloon Versus Endoscopic Sleeve Gastroplasty for the Treatment of Obesity: a Systematic Review and Meta-analysis
Authors: Shailendra Singh
Diogo Turiani Hourneaux de Moura
Ahmad Khan
Mohammad Bilal
Monica Chowdhry
Michele B. Ryan
Ahmad Najdat Bazarbashi
Christopher C. Thompson
Publication date: 01-08-2020
Publisher: Springer US
Keywords: Obesity
Obesity
Published in: Obesity Surgery / Issue 8/2020
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-020-04644-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Intragastric Balloon Versus Endoscopic Sleeve Gastroplasty for the Treatment of Obesity: a Systematic Review and Meta-analysis

Abstract

Background

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2020

Gastroesophageal Reflux Disease, Obesity, and Roux-en-Y Gastric Bypass: Complex Relationship—a Narrative Review

Correction to: Preoperative Upper-GI Endoscopy Prior to Bariatric Surgery: Essential or Optional?

Case Report: Phytobezoar Causing Gastric Outlet Obstruction as a Late Complication After Biliopancreatic Diversion with Duodenal Switch

A French National Study on Gastropleural and Gastrobronchial Fistulas After Bariatric Surgery: the Impact of Therapeutic Strategy on Healing

A Qualitative Exploration of Patients’ Experiences with Lifestyle Changes After Sleeve Gastrectomy in China

Relationship of Food Intolerance 2 Years After Roux-en-Y Gastric Bypass Surgery for Obesity with Masticatory Efficiency and Protein Consumption